REGN
Price
$555.13
Change
-$14.77 (-2.59%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
60.4B
85 days until earnings call
SLXN
Price
$8.30
Change
-$0.56 (-6.32%)
Updated
Aug 6, 04:51 PM (EDT)
Capitalization
5.13M
Interact to see
Advertisement

REGN vs SLXN

Header iconREGN vs SLXN Comparison
Open Charts REGN vs SLXNBanner chart's image
Regeneron Pharmaceuticals
Price$555.13
Change-$14.77 (-2.59%)
Volume$89.32K
Capitalization60.4B
Silexion Therapeutics
Price$8.30
Change-$0.56 (-6.32%)
Volume$200
Capitalization5.13M
REGN vs SLXN Comparison Chart in %
Loading...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REGN vs. SLXN commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REGN is a Hold and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (REGN: $569.90 vs. SLXN: $8.86)
Brand notoriety: REGN: Notable vs. SLXN: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REGN: 88% vs. SLXN: 38%
Market capitalization -- REGN: $60.4B vs. SLXN: $5.13M
REGN [@Biotechnology] is valued at $60.4B. SLXN’s [@Biotechnology] market capitalization is $5.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REGN’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 1 green FA rating(s).

  • REGN’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 1 green, 4 red.
According to our system of comparison, REGN is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REGN’s TA Score shows that 7 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • REGN’s TA Score: 7 bullish, 3 bearish.
  • SLXN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, REGN is a better buy in the short-term than SLXN.

Price Growth

REGN (@Biotechnology) experienced а +2.11% price change this week, while SLXN (@Biotechnology) price change was -28.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.67%. For the same industry, the average monthly price growth was +14.79%, and the average quarterly price growth was +13.41%.

Reported Earning Dates

REGN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-0.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($60.4B) has a higher market cap than SLXN($5.13M). REGN YTD gains are higher at: -19.774 vs. SLXN (-70.614). REGN has higher annual earnings (EBITDA): 5.42B vs. SLXN (-16.96M). SLXN has less debt than REGN: SLXN (3.48M) vs REGN (2.71B). REGN has higher revenues than SLXN: REGN (14.2B) vs SLXN (0).
REGNSLXNREGN / SLXN
Capitalization60.4B5.13M1,176,471%
EBITDA5.42B-16.96M-31,969%
Gain YTD-19.774-70.61428%
P/E Ratio14.36N/A-
Revenue14.2B0-
Total Cash7.47BN/A-
Total Debt2.71B3.48M77,685%
FUNDAMENTALS RATINGS
REGN: Fundamental Ratings
REGN
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
54
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REGNSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
39%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
8%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
20%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
31%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
42%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 10 days ago
51%
Declines
ODDS (%)
Bearish Trend 7 days ago
56%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
56%
Bullish Trend 2 days ago
44%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IYM142.691.69
+1.20%
iShares US Basic Materials ETF
WBIF29.310.01
+0.03%
WBI BullBear Value 3000 ETF
MCDS55.21N/A
N/A
JPMorgan Fundamental Data Sci Md Cor ETF
UAUG38.19-0.07
-0.18%
Innovator U.S. Equity Ultra BufferETFAug
URTH170.84-0.58
-0.34%
iShares MSCI World ETF

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.99%
IMA - SLXN
59%
Loosely correlated
-0.66%
CELC - SLXN
50%
Loosely correlated
-0.67%
MRSN - SLXN
43%
Loosely correlated
+2.62%
CHRS - SLXN
26%
Poorly correlated
+4.86%
QSI - SLXN
25%
Poorly correlated
N/A
More